Pluri (PLUR) Gross Margin (2011 - 2025)
Pluri (PLUR) posted quarterly Gross Margin of 43.43% for Q4 2025, down 1657.0% year-over-year from 2.79% in Q4 2024, and up 19.35% quarter-over-quarter from 36.39% in Q3 2025.
Pluri (PLUR) Gross Margin (2011 - 2025) Analysis & Trends
Pluri (PLUR) has reported Gross Margin for 11 consecutive years, with 43.43% the latest figure, recorded in Q4 2025.
- In Q4 2025, Gross Margin fell 1657.0% year-over-year to 43.43%; the TTM figure through Dec 2025 stood at 40.63% (down 2928.0% YoY), while the FY2025 annual figure was 48.95%, down 4982.0% from the prior year.
- Gross Margin advanced to 43.43% in Q4 2025 per PLUR's latest filing, from 36.39% in the prior quarter.
- Across five years, Gross Margin topped out at 100.0% in Q3 2023 and bottomed at 31.85% in Q1 2025.
- Historically, Gross Margin has averaged 68.09% across 3 years, with a median of 60.67% in 2024.
- On a YoY basis, Gross Margin climbed as much as 1657 bps in 2025 and fell as far as 6815 bps in 2025.
- Pluri's Gross Margin stood at 100.0% in 2023, then sank by 40 bps to 60.0% in 2024, then fell by 28 bps to 43.43% in 2025.
- Business Quant data shows PLUR's Gross Margin at 43.43% in Q4 2025, 36.39% in Q3 2025, and 52.01% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.57 Bn | 130.72 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 77.99 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 65.00 Bn | 59.82 Bn | 1.37 Bn | 90.43% |
| 4 | Moderna | 56.27 Bn | 51.13 Bn | 52.00 Mn | 35.86% |
| 5 | BeOne Medicines | 42.00 Bn | 36.90 Bn | 1.53 Bn | 89.76% |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn | 76.90% |
| 7 | BioNTech SE | 27.68 Bn | 9.29 Bn | 668.28 Mn | 63.27% |
| 8 | Insmed | 27.43 Bn | 26.27 Bn | 358.27 Mn | 84.20% |
| 9 | Royalty Pharma | 27.34 Bn | 26.51 Bn | - | - |
| 10 | Pluri | 16.21 Mn | 3.72 Mn | 86,000.00 | 43.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 43.43% |
| Sep 30, 2025 | 36.39% |
| Jun 30, 2025 | 52.01% |
| Mar 31, 2025 | 31.85% |
| Dec 31, 2024 | 60.00% |
| Sep 30, 2024 | 61.35% |
| Jun 30, 2024 | 95.83% |
| Mar 31, 2024 | 100.00% |
| Dec 31, 2023 | 100.00% |
| Sep 30, 2023 | 100.00% |
| Dec 31, 2019 | 95.65% |
| Dec 31, 2018 | 96.00% |
| Sep 30, 2018 | 100.00% |
| Dec 31, 2017 | 96.00% |
| Dec 31, 2015 | 96.48% |
| Sep 30, 2015 | 96.84% |
| Dec 31, 2014 | 95.79% |
| Sep 30, 2014 | 96.84% |
| Jun 30, 2014 | 97.87% |
| Mar 31, 2014 | 96.84% |